GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Institutional Ownership

SyntekaBio (XKRX:226330) Institutional Ownership : 0.07% (As of Jul. 09, 2025)


View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SyntekaBio's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SyntekaBio's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SyntekaBio's Float Percentage Of Total Shares Outstanding is 0.00%.


SyntekaBio Institutional Ownership Historical Data

The historical data trend for SyntekaBio's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Institutional Ownership Chart

SyntekaBio Historical Data

The historical data trend for SyntekaBio can be seen below:

2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30
Institutional Ownership 0.96 0.63 0.99 0.63 0.35 0.36 0.37 0.07 0.07 0.07

SyntekaBio Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


SyntekaBio Business Description

Traded in Other Exchanges
N/A
Address
187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512
SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio Headlines

No Headlines